PRESS RELEASE published on 01/25/2024 at 15:07, 2 years 2 months ago CMUV Bancorp Announces 2023 4th Quarter Financial Results CMUV Bancorp, the holding company for Community Valley Bank, announces unaudited year-end results for 2023. The financial results show solid performance with total assets reaching $297 MM and a strong Community Bank Capital Leverage ratio of 11.80%. Despite challenges in the banking environment, CVB sustained deposits and exceeded budgeted loan targets. The Board of Directors approved a share buyback and increased quarterly dividend, demonstrating commitment to delivering outstanding value to shareholders. Financial Results Share Buyback CMUV Bancorp Community Valley Bank Year-end
Published on 04/09/2026 at 16:00, 2 hours 34 minutes ago Banff Half Marathon Completes 2025 Emissions Assessment, Supporting Climate Action with Karbon-X
Published on 04/09/2026 at 14:40, 3 hours 54 minutes ago Silver X Delivers Production Growth During the First Quarter of 2026
Published on 04/09/2026 at 14:00, 4 hours 34 minutes ago Orogen Royalties Announces Mineral Reserve and Resource Update on Producing Ermitaño Royalty
Published on 04/09/2026 at 13:30, 5 hours 4 minutes ago Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate
Published on 04/09/2026 at 13:30, 5 hours 4 minutes ago ESGold Advances Toward Production and Exploration Drilling as Mill Buildout Progresses in Parallel
Published on 04/09/2026 at 18:15, 18 minutes ago REPLY: Launch of a share buyback program for a maximum number of 3,607,950 shares
Published on 04/09/2026 at 15:40, 2 hours 54 minutes ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Published on 04/09/2026 at 15:39, 2 hours 54 minutes ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 04/09/2026 at 15:57, 2 hours 36 minutes ago Filing of CNP Assurances SA 2025 universal registration document and 2025 Solvency and Financial Condition Reports
Published on 04/09/2026 at 07:00, 11 hours 34 minutes ago bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing